Fertility and Sterility/LinkedIn
Feb 2, 2026, 13:04
Optimal GnRH Agonist Dosage for Oocyte Maturation – Fertility and Sterility
Fertility and Sterility shared a post on LinkedIn:
“Optimal gonadotropin-releasing hormone agonist dosage for oocyte maturation in low-prognosis patients: Interim analysis of a randomized controlled trial
Title: Optimal gonadotropin-releasing hormone agonist dosage for oocyte maturation in low-prognosis patients: interim analysis of a randomized controlled trial in Patient-Oriented Strategies Encompassing IndividualizeD Oocyte groups 3 and 4
Authors: Anjali Gahlan, Matheus Roque, Akanksha Jangid, Amrita Das, Pawan Yadav, Shashank Sangoudar, Kshitiz Murdia, Amol Lunkad, Vipin Chandra, Nitiz Murdia, Isha Suwalka, Walmik Mistari
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Aug 3, 2026, 14:19Asmaa Khaled: The Success of IVF is Not Determined By the Number of Eggs Retrieved Alone…
-
Aug 3, 2026, 14:03Clare Mansfield: Sometimes the Path to Parenthood Changes, but the Dream Doesn’t Have To
-
Aug 3, 2026, 13:45Undiga Emuekpere: Basic Fertility Health Awareness Could Change Outcomes
-
Aug 3, 2026, 13:31Priyadatt Patel: A Quiet Inefficiency in How We Approach Infertility Deserves More Attention
-
Aug 3, 2026, 13:21Purabi Gunjal: Most Women Start Thinking about Fertility Too Late…
-
Aug 3, 2026, 13:10Juhee Jain: Empowering Women with the Right Information to Make Informed Decisions
-
Aug 3, 2026, 12:57Ashley Evans: Sometimes, the Thing that Got Me Through Fertility Treatment Wasn’t Positivity…
-
Aug 3, 2026, 12:42Devyanshi Dixit: Why Do the Best Healthcare Professionals Never Stop Learning?
-
Aug 3, 2026, 12:30Bringing Together the Brightest Minds in Reproductive Medicine for 3 Days at MEFS 2026